In December 2006 GroPep was acquired by the Danish company Novozymes A/S and became Novozymes GroPep Limited.

Novozymes GroPep sells growth factors and associated reagents direct to university, institutional an industrial researchers, principally in the insulin-like growth factor - IGF area. Our product range consists of over 100 products. We also have a world wide network of specialised distributors.

We have considerable experience in the molecular biology, fermentation and processing required for the manufacture of recombinant proteins and monoclonal antibodies. This has resulted in the development of a number of proprietary manufacturing technologies.

Novozymes GroPep differentiates itself from other reagents distributors through its strong scientific and technical support of its products. Novozymes GroPep's penetration of the insulin-like growth factor (IGF) research market is based on an established presence and involvement in the IGF research field by Novozymes GroPep staff and its collaborative partners.

Novozymes GroPep sources new products from its own R & D programs and from its research customer base. We have a collaborative agreement with ImmunoDiagnostic Systems (UK) for the joint development and marketing of immunoassay (ELISA) kits for use in the research and diagnostic markets.

Novozymes GroPep welcomes enquiries from researchers with purified growth factors, antisera and related reagents who are interested in commercialising them through Novozymes GroPep.

We offer a special service to manufacture bulk quantities for large scale users.

Through this website, all product and technical support information is available 24/7 to researchers anywhere in the world. Products can also be ordered online via our secure ordering system.